51 related articles for article (PubMed ID: 21562945)
1. Clinical efficacy of chemotherapy combined with verapamil in metastatic colorectal patients.
Liu Y; Lu Z; Fan P; Duan Q; Li Y; Tong S; Hu B; Lv R; Hu L; Zhuang J
Cell Biochem Biophys; 2011 Nov; 61(2):393-8. PubMed ID: 21562945
[TBL] [Abstract][Full Text] [Related]
2. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].
Zhao Y; Wang SM; Zhang J
Ai Zheng; 2002 Apr; 21(4):421-3. PubMed ID: 12452025
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C
Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pretreatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy.
Lissoni P; Brivio F; Fumagalli L; Di Fede G; Brera G
In Vivo; 2005; 19(6):1077-80. PubMed ID: 16277025
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M;
J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
[TBL] [Abstract][Full Text] [Related]
9. Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.
Bouchahda M; Adam R; Giacchetti S; Castaing D; Brezault-Bonnet C; Hauteville D; Innominato PF; Focan C; Machover D; Lévi F
Cancer; 2009 Nov; 115(21):4990-9. PubMed ID: 19637365
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
[TBL] [Abstract][Full Text] [Related]
11. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
Sugimoto M; Yasuda H; Koda K; Yamazaki M; Tezuka T; Takenoue T; Kosugi C; Higuchi R; Yamamoto S; Watayo Y; Yagawa Y; Suzuki M
Hepatogastroenterology; 2007 Sep; 54(78):1684-8. PubMed ID: 18019695
[TBL] [Abstract][Full Text] [Related]
12. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
14. Basic and clinical research on the therapeutic effect of intervention in primary liver cancer by targeted intra-arterial verapamil infusion.
Pingsheng F; Tengyue Z; Qiang H; Qiang W; Xin S; Liting Q
Cell Biochem Biophys; 2012 Jan; 62(1):59-67. PubMed ID: 21830124
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of chemotherapy combined with targeted arterial infusion of verapamil in patients with advanced gastric cancer.
Ning Z; Chen D; Liu A; Fan P; Duan Q; Zhang T; Fan G
Cell Biochem Biophys; 2014 Jan; 68(1):195-200. PubMed ID: 23737342
[TBL] [Abstract][Full Text] [Related]
16. Treatment of malignant ascites with a combination of chemotherapy drugs and intraperitoneal perfusion of verapamil.
Jia W; Zhu Z; Zhang T; Fan G; Fan P; Liu Y; Duan Q
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1585-90. PubMed ID: 23589316
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma.
Huang J; Duan Q; Fan P; Ji C; Lv Y; Lin X; Qian L; Yu X
Cell Biochem Biophys; 2011 Mar; 59(2):127-32. PubMed ID: 20963512
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effects of target artery infusion of verapamil and chemotherapy drugs on advanced non-small cell lung cancer].
Tan YF; Ma HX; Zhao B; Zhang HR
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):486-490. PubMed ID: 32575945
[No Abstract] [Full Text] [Related]
19. The DNA Repair Inhibitor DT01 as a Novel Therapeutic Strategy for Chemosensitization of Colorectal Liver Metastasis.
Herath NI; Devun F; Lienafa MC; Herbette A; Denys A; Sun JS; Dutreix M
Mol Cancer Ther; 2016 Jan; 15(1):15-22. PubMed ID: 26637369
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy resistance and retreatment: a dogma revisited.
Naing A; Kurzrock R
Clin Colorectal Cancer; 2010 Apr; 9(2):E1-4. PubMed ID: 20378496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
